Niquitin Mini Citrus (Nicotine)

Nicotine, the active ingredient in Niquitin Mini Citrus, is a nicotinic receptor agonist presented as an oromucosal product for oromucosal use. It is employed to aid adult smokers in quitting by reducing nicotine withdrawal symptoms and cravings, supporting a gradual reduction in tobacco dependence.

GNH USA supplies Niquitin Mini Citrus as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to pharmacies and clinics worldwide under strict quality standards. The company ensures batch traceability, proper labeling, and compliance with EU regulatory requirements for over‑the‑counter nicotine products.

Nicotine, a nicotinic receptor agonist, is used in smoking cessation to manage nicotine dependence.

- Smoking cessation: helps adult smokers reduce withdrawal symptoms and cravings during quit attempts. - Tobacco dependence: supports gradual reduction of nicotine intake in individuals seeking to quit tobacco use. - Relapse prevention: assists former smokers in maintaining abstinence by mitigating occasional cravings.

Oral mucosal nicotine products may cause a range of adverse reactions, from mild irritation to rare serious events.

Common Side Effects: - Mouth irritation: tingling or soreness in the oral cavity. - Throat irritation: discomfort or scratchy feeling in the throat. - Nausea: mild stomach upset after use.

Serious or Rare Side Effects: - Increased blood pressure: notable rise in systolic or diastolic pressure. - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing.

When using Niquitin Mini Citrus, consider the following precautions to ensure safe and effective use.

- Cardiovascular assessment: evaluate patients with hypertension or recent cardiac events before use. - Pregnancy and lactation: avoid use during pregnancy or breastfeeding unless benefits outweigh risks, as safety data are limited. - Age restriction: not recommended for individuals under 18 years of age. - Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent excess exposure. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine may interact with other medicines; awareness of these interactions helps minimize adverse outcomes.

Major Interactions (Avoid): - CYP2A6 inhibitors: may increase nicotine plasma levels, raising risk of toxicity. - Monoamine oxidase inhibitors (MAOIs): concurrent use can amplify cardiovascular effects such as hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be blunted, requiring dose adjustment. - Antidepressants (SSRIs): nicotine can alter metabolism, potentially affecting drug concentrations. - Antihypertensive agents: nicotine may reduce the efficacy of blood pressure medications.